Skip to content
Trial Eligibility
Menu

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

NCT05711394

This study is recruiting at 26 US sites in 17 states, according to its ClinicalTrials.gov record last updated .

Summary

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. A number of treatments are available for adults with migraine but there are limited approved treatments available for pediatric participants. The main goal of the study is to evaluate the safety and efficacy (how well treatment works) of a low-dose and high-dose of atogepant in pediatric participants between the ages of 6 and 17.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Episodic Migraine

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
6 to 17 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
AbbVie
Last updated on ClinicalTrials.gov
October 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 2

  • Rehabilitation & Neurological Services /ID# 248517 · Huntsville, AL
  • The Center for Clinical Trials - Saraland /ID# 271604 · Saraland, AL

Arkansas · 1

  • Preferred Research Partners /ID# 249729 · Little Rock, AR

California · 4

  • Advanced Research Center /ID# 251381 · Anaheim, CA
  • Alliance for Research Alliance for Wellness /ID# 248521 · Long Beach, CA
  • Lumos Clinical Research Center /ID# 249731 · San Jose, CA
  • Sunwise Clinical Research /ID# 248529 · Walnut Creek, CA

Florida · 1

  • My Preferred Research LLC /ID# 249720 · Miami, FL

Georgia · 1

  • Coastal Georgia Child Neurology /ID# 249733 · Brunswick, GA

Indiana · 1

  • Deaconess Clinic - Gateway Health Center /ID# 247589 · Newburgh, IN

Michigan · 1

  • Michigan Headache & Neurological Institute (MHNI) /ID# 247468 · Ann Arbor, MI

Mississippi · 1

  • Proven Endpoints LLC /ID# 258066 · Ridgeland, MS

New Jersey · 1

  • Goryeb Childrens Hospital /ID# 249724 · Morristown, NJ

New York · 1

  • Dent Neurologic Institute - Amherst /ID# 248534 · Amherst, NY

North Carolina · 1

  • Headache Wellness Center /ID# 251018 · Greensboro, NC

Ohio · 2

  • Cincinnati Childrens Hospital Medical Center /ID# 258070 · Cincinnati, OH
  • Patient Priority Clinical Sites, LLC /ID# 247535 · Cincinnati, OH

Pennsylvania · 1

  • Children's Hospital of Philadelphia - Main /ID# 258071 · Philadelphia, PA

Tennessee · 1

  • Access Clinical Trials, Inc. /ID# 248532 · Nashville, TN

Texas · 3

  • UT Health Austin at Dell Children's Neurology Clinic /ID# 264082 · Austin, TX
  • Earle Research /ID# 248501 · Friendswood, TX
  • ClinPoint Trials /ID# 248540 · Waxahachie, TX

Utah · 3

  • Pantheon Clinical Research /ID# 251601 · Bountiful, UT
  • Alpine Research Organization - Clinton /ID# 276497 · Clinton, UT
  • Highland Clinical Research /ID# 247590 · Salt Lake City, UT

Virginia · 1

  • Office of Maria Ona /ID# 249738 · Franklin, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.